arrow
C

Camille L. Gérard

precision oncology center
H指数:18
被引数:2,167

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
2025-01-010
OAAI
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma
2024-02-060
PRE
Multilingual RECIST classification of radiology reports using supervised learning

使用监督学习对放射学报告进行多语言RECIST分类

2023-06-141
OAAI
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

晚期转移性黑色素瘤通过多种进化途径出现

2023-03-2819
OAAI
A differential process mining analysis of COVID-19 management for cancer patients

癌症患者新型冠状病毒肺炎管理的差异化过程挖掘分析

2022-12-074
OAAI
Advanced melanoma exhibits a diversity of evolutionary routes to lethality

晚期黑色素瘤表现出致死率的进化途径的多样性

2022-05-150
PRE
Advanced melanoma exhibits a diversity of evolutionary routes to lethality
2022-05-150
PRE
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
2021-10-27130
OAAI
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
2021-10-2744
OA
Real-life data for first-line combination immune- checkpoint inhibition and targeted therapy in patients with melanoma brain metastases

黑色素瘤脑转移患者一线联合免疫检查点抑制和靶向治疗的真实数据

2021-10-0111
OAAI
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
2021-07-15118
OAAI
Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
2021-07-0187
PREAI
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
2021-05-2671
OAAI